Overview

Fentanyl for Breakthrough Pain in the Emergency Department

Status:
Terminated
Trial end date:
2014-10-22
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if fentanyl nasal spray can help decrease pain related to cancer when used with other drugs for pain. Researchers also want to know if this drug can help decrease the length of your stay in the Emergency Department. In this study, fentanyl nasal spray will be compared to a placebo nasal spray. A placebo is not a drug. It looks like the study drug but it is not designed to treat any disease or illness. It is designed in this study to be compared with the study spray to learn if the study spray has any real effect. You will also be given intravenous (IV) pain drugs. You will be given these drugs even if you decide not to take part in this study.
Phase:
Phase 4
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Archimedes Pharma US, Inc.
Treatments:
Fentanyl
Hydromorphone